Login / Signup

Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment.

Alanood S AlmurshediHessah A AljunaidelBushra T ALquadeibBasmah N AldosariIman M AlfagihSalma S AlmarshidyEram K D EltahirAmany Z Mohamoud
Published in: International journal of nanomedicine (2021)
Novel inhalable CIP NCMP powders are a potential new approach to improved target ability and delivery of CIP for NCFB treatment.
Keyphrases
  • cystic fibrosis
  • pseudomonas aeruginosa
  • risk assessment
  • combination therapy
  • fatty acid
  • human health